| Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition M Sciacovelli, E Gonçalves, TI Johnson, VR Zecchini, ASH Da Costa, ... Nature 537 (7621), 544-547, 2016 | 517 | 2016 |
| Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia HM Thol F, Damm F, Lüdeking A, Winschel C, Wagner K, Morgan M, Yun H ... J Clin Oncol 29, 2889-2896, 2011 | 474 | 2011 |
| Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes F Thol, I Friesen, F Damm, H Yun, EM Weissinger, J Krauter, K Wagner, ... Journal of Clinical Oncology 29 (18), 2499-2506, 2011 | 349 | 2011 |
| Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML A Chaturvedi, MM Araujo Cruz, N Jyotsana, A Sharma, H Yun, K Görlich, ... Blood, The Journal of the American Society of Hematology 122 (16), 2877-2887, 2013 | 241 | 2013 |
| Single Nucleotide Polymorphism in the Mutational Hotspot of WT1 Predicts a Favorable Outcome in Patients With Cytogenetically Normal Acute Myeloid Leukemia F Damm, M Heuser, M Morgan, H Yun, A Großhennig, G Göhring, ... Journal of Clinical Oncology 28 (4), 578-585, 2010 | 155 | 2010 |
| Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition P Gallipoli, G Giotopoulos, K Tzelepis, ASH Costa, S Vohra, ... Blood 131 (15), 1639-1653, 2018 | 148 | 2018 |
| UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs M Gozdecka, E Meduri, M Mazan, K Tzelepis, M Dudek, AJ Knights, ... Nature genetics 50 (6), 883-894, 2018 | 136 | 2018 |
| Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex M Heuser, H Yun, T Berg, E Yung, B Argiropoulos, F Kuchenbauer, ... Cancer cell 20 (1), 39-52, 2011 | 113 | 2011 |
| Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML F Basheer, G Giotopoulos, E Meduri, H Yun, M Mazan, D Sasca, ... Journal of Experimental Medicine 216 (4), 966-981, 2019 | 102 | 2019 |
| Rare occurrence of DNMT3A mutations in myelodysplastic syndromes F Thol, C Winschel, A Lüdeking, H Yun, I Friesen, F Damm, K Wagner, ... Haematologica 96 (12), 1870, 2011 | 100 | 2011 |
| Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors SJ Horton, G Giotopoulos, H Yun, S Vohra, O Sheppard, ... Nature cell biology 19 (9), 1093-1104, 2017 | 69 | 2017 |
| Epigenetics in myelodysplastic syndromes M Heuser, H Yun, F Thol Seminars in cancer biology 51, 170-179, 2018 | 65 | 2018 |
| Genetic characterization of acquired aplastic anemia by targeted sequencing M Heuser, C Schlarmann, V Dobbernack, V Panagiota, L Wiehlmann, ... Haematologica 99 (9), e165, 2014 | 64 | 2014 |
| Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia JY Shi, ZH Ren, B Jiao, R Xiao, HY Yun, B Chen, WL Zhao, Q Zhu, ... International journal of cancer 128 (1), 233-238, 2011 | 61 | 2011 |
| Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies D Sasca, H Yun, G Giotopoulos, J Szybinski, T Evan, NK Wilson, ... Blood 134 (24), 2195-2208, 2019 | 47 | 2019 |
| Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes F Thol, H Yun, AK Sonntag, F Damm, EM Weissinger, J Krauter, K Wagner, ... Annals of hematology 91 (8), 1221-1233, 2012 | 47 | 2012 |
| Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling A Sharma, H Yun, N Jyotsana, A Chaturvedi, A Schwarzer, E Yung, ... Leukemia 29 (1), 157-168, 2015 | 42 | 2015 |
| A new fusion gene NUP98-IQCG identified in an acute T-lymphoid/myeloid leukemia with at (3; 11)(q29q13; p15) del (3)(q29) translocation Q Pan, YJ Zhu, BW Gu, X Cai, XT Bai, HY Yun, J Zhu, B Chen, L Weng, ... Oncogene 27 (24), 3414-3423, 2008 | 34 | 2008 |
| Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemia H Yun, F Damm, D Yap, A Schwarzer, A Chaturvedi, N Jyotsana, ... haematologica 99 (9), 1456, 2014 | 30 | 2014 |
| Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression H Yun, N Narayan, S Vohra, G Giotopoulos, A Mupo, P Madrigal, D Sasca, ... Nature genetics 53 (10), 1443-1455, 2021 | 21 | 2021 |
